D
David Spiegel
Researcher at Stanford University
Publications - 838
Citations - 50967
David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Congenital vertebral anomalies in ischiopagus and pyopagus conjoined twins.
TL;DR: Observations suggest an association between ischiopagus and pyopagus conjoined twins and congenital vertebral anomalies, and their coexistence is explained best by a nonspecific teratogenic insult during early embryogenesis.
Journal ArticleDOI
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.
Nahid Tabibzadeh,Angelo Karaboyas,Bruce M. Robinson,Philipp A. Csomor,David Spiegel,Pieter Evenepoel,Stefan H. Jacobson,Pablo-Antonio Ureña-Torres,Masafumi Fukagawa,Issa Al Salmi,Xinling Liang,Ronald L. Pisoni,Eric W. Young +12 more
TL;DR: Increased PTH before HD start predicted a higher PTH level 9–12 months later, despite greater use of active vitamin D and calcimimetics, raising the need for PTH target guidelines in these patients.
Book Chapter
A multisite study of acute stress reactions to a disaster
Etzel Cardeña,Are Holen,Alexander C. McFarlane,Zahava Solomon,Charles Wilkinson,David Spiegel +5 more
Journal ArticleDOI
Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.
Kwang Min Lee,Doo young Jung,Heesung Hwang,Won-Hyoung Kim,Jooyoung Lee,Tae Yong Kim,Seock-Ah Im,Kyung Hun Lee,David Spiegel,Bong Jin Hahm +9 more
TL;DR: In women with breast cancer undergoing neoadjuvant chemotherapy before surgery, late chronotypes were found to have an increased risk of CINV; these data suggest that clinicians need to assess and consider the chronotype in the management of CinV.